Comparing Entyvio vs Mesalamine
| Entyvio | Mesalamine |
|
|---|
| Entyvio (vedolizumab) | Mesalamine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Entyvio is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically instead of... View more |
Prescription only
Prescribed for Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Ulcerative Proctitis, Ulcerative Colitis. May also be... View more |
Related suggestions Ulcerative Colitis
Crohn's Disease
Popular comparisons
|
|||||||||||||||
| More about Entyvio (vedolizumab) | More about Mesalamine | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Entyvio has an average rating of 5.7 out of 10 from a total of 128 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 34% reported a negative effect. |
Mesalamine has an average rating of 7.0 out of 10 from a total of 403 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Entyvio side effects in more detail. |
Commonly reported side effects include:
See also: mesalamine side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Entyvio prices |
View all mesalamine prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
600 hours |
10 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 137 drugs are known to interact with Entyvio:
|
A total of 119 drugs are known to interact with mesalamine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 20, 2014 |
January 31, 1992 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.